These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16715412)

  • 41. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2.
    Pokhrel S; Bouback TA; Samad A; Nur SM; Alam R; Abdullah-Al-Mamun M; Nain Z; Imon RR; Talukder MEK; Tareq MMI; Hossen MS; Karpiński TM; Ahammad F; Qadri I; Rahman MS
    Int J Biol Macromol; 2021 Nov; 191():1114-1125. PubMed ID: 34592225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
    Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
    J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effects of 190 compounds against SARS-CoV-2 M
    Souza GB; Sens L; Hammerschmidt SJ; de Sousa NF; de Carvalho MAG; Dos Santos CVD; Tizziani T; Moreira MA; Pollo LAE; Martin EF; Neto JSS; Biavatti MW; de Assis FF; Ngadjui BT; Simo IK; Ambassa P; Scotti MT; Scotti L; Braga AL; Schirmeister T; Sandjo LP
    Arch Pharm (Weinheim); 2023 Aug; 356(8):e2300207. PubMed ID: 37255416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of New Hydroxyethylamine Analogs against 3CL
    Kumar S; Sharma PP; Shankar U; Kumar D; Joshi SK; Pena L; Durvasula R; Kumar A; Kempaiah P; Poonam ; Rathi B
    J Chem Inf Model; 2020 Dec; 60(12):5754-5770. PubMed ID: 32551639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease.
    Ngo ST; Quynh Anh Pham N; Thi Le L; Pham DH; Vu VV
    J Chem Inf Model; 2020 Dec; 60(12):5771-5780. PubMed ID: 32530282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sometimes intermediates. Do the job!
    Hilgenfeld R; Pumpor K
    Chem Biol; 2006 Mar; 13(3):235-6. PubMed ID: 16638527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of SARS-CoV 3CL protease by flavonoids.
    Jo S; Kim S; Shin DH; Kim MS
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):145-151. PubMed ID: 31724441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
    Kao RY; Tsui WH; Lee TS; Tanner JA; Watt RM; Huang JD; Hu L; Chen G; Chen Z; Zhang L; He T; Chan KH; Tse H; To AP; Ng LW; Wong BC; Tsoi HW; Yang D; Ho DD; Yuen KY
    Chem Biol; 2004 Sep; 11(9):1293-9. PubMed ID: 15380189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.
    Shie JJ; Fang JM; Kuo CJ; Kuo TH; Liang PH; Huang HJ; Yang WB; Lin CH; Chen JL; Wu YT; Wong CH
    J Med Chem; 2005 Jun; 48(13):4469-73. PubMed ID: 15974598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding.
    Turlington M; Chun A; Tomar S; Eggler A; Grum-Tokars V; Jacobs J; Daniels JS; Dawson E; Saldanha A; Chase P; Baez-Santos YM; Lindsley CW; Hodder P; Mesecar AD; Stauffer SR
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6172-7. PubMed ID: 24080461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantum simulations of SARS-CoV-2 main protease M
    Wang Y; Murlidaran S; Pearlman DA
    J Comput Aided Mol Des; 2021 Sep; 35(9):963-971. PubMed ID: 34328586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds.
    Ton AT; Gentile F; Hsing M; Ban F; Cherkasov A
    Mol Inform; 2020 Aug; 39(8):e2000028. PubMed ID: 32162456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M
    Ghosh A; Chakraborty M; Chandra A; Alam MP
    J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights on 3D Structures of Potential Drug-targeting Proteins of SARS-CoV-2: Application of Cavity Search and Molecular Docking.
    Fernandes MS; da Silva FS; Freitas ACSG; de Melo EB; Trossini GHG; Paula FR
    Mol Inform; 2021 Feb; 40(2):e2000096. PubMed ID: 32750187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repurposing immune boosting and anti-viral efficacy of
    Dinata R; Nisa N; Arati C; Rasmita B; Uditraj C; Siddhartha R; Bhanushree B; Saeed-Ahmed L; Manikandan B; Bidanchi RM; Abinash G; Pori B; Khushboo M; Roy VK; Gurusubramanian G
    J Biomol Struct Dyn; 2024; 42(1):43-81. PubMed ID: 37021347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase.
    Birch L; Murray CW; Hartshorn MJ; Tickle IJ; Verdonk ML
    J Comput Aided Mol Des; 2002 Dec; 16(12):855-69. PubMed ID: 12825619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus.
    Qiao Z; Wei N; Jin L; Zhang H; Luo J; Zhang Y; Wang K
    Bioorg Chem; 2021 Dec; 117():105455. PubMed ID: 34740055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors.
    Ghosh AK; Xi K; Ratia K; Santarsiero BD; Fu W; Harcourt BH; Rota PA; Baker SC; Johnson ME; Mesecar AD
    J Med Chem; 2005 Nov; 48(22):6767-71. PubMed ID: 16250632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease.
    Varadharajan V; Arumugam GS; Shanmugam S
    J Biomol Struct Dyn; 2022 Oct; 40(17):7852-7867. PubMed ID: 33764269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton-Coupled Conformational Activation of SARS Coronavirus Main Proteases and Opportunity for Designing Small-Molecule Broad-Spectrum Targeted Covalent Inhibitors.
    Verma N; Henderson JA; Shen J
    J Am Chem Soc; 2020 Dec; 142(52):21883-21890. PubMed ID: 33320670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.